Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
Condition(s):Pancreatic CancerLast Updated:July 9, 2012Unknown status
Hide Studies Not Open or Pending
Condition(s):Pancreatic CancerLast Updated:July 9, 2012Unknown status
Condition(s):Malignant Neoplasm of Stomach; Secondary Malignant Neoplasm of Peritoneum; Secondary Malignant Neoplasm of Other and Unspecified SitesLast Updated:July 29, 2021Completed
Condition(s):Pancreatic CancerLast Updated:February 13, 2018Terminated
Condition(s):Advanced Breast Cancer; Treatment; HR Low/HER2 NegativeLast Updated:December 19, 2023Not yet recruiting
Condition(s):Pancreatic CancerLast Updated:August 7, 2015Completed
Condition(s):Advanced Gastrointestinal Malignancies; Solid TumorsLast Updated:April 23, 2013Completed
Condition(s):Liver CancerLast Updated:July 12, 2017Completed
Condition(s):Rectal NeoplasmsLast Updated:September 18, 2009Completed
Condition(s):CancerLast Updated:July 15, 2019Terminated
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:February 10, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.